Ninth Circuit Narrows Qualifications for Being Qui Tam "Original Source"
Client Alert | 1 min read | 11.04.14
The Ninth Circuit, in Malhotra v. Steinberg (Oct. 29, 2014), held that, despite tipping off the government as to one kind of wrongdoing by the defendant, the FCA relators were not the "original source" of a different alleged act of wrongdoing perpetrated by the same defendant, a bankruptcy trustee. The relators independently discovered and alerted federal authorities to defendant trustee's scheme to sell property at a price lower than fair market value, but because that federal investigation led to the public disclosure of the defendant's receipt of kickbacks from those sales, the court held that the relators were not the original source of the kickback allegation which formed the basis of their qui tam action.
Insights
Client Alert | 6 min read | 09.03.26
FDA Seeks Input for Regulating GenAI-Powered Medical Devices
The U.S. Food & Drug Administration (FDA) is seeking feedback on a regulatory framework that could be used to evaluate generative artificial intelligence (GenAI)-enabled medical devices. Such devices could create new types of risks because their outputs can vary and evolve, unlike more traditional software-enabled devices. An August 18, 2026, discussion paper (“Considerations for the regulation of GenAI-enabled medical devices”) discusses potential regulatory considerations for GenAI-enabled medical devices.
Client Alert | 5 min read | 09.02.26
DOJ’s Civil Rights Fraud Initiative Claims Another DEI-Related FCA Settlement
Client Alert | 4 min read | 09.02.26
Client Alert | 3 min read | 09.02.26
